@jamesthomson and it was absolutely great - we could focus on improving our software rather than playing catchup with the latest fad.
-
-
-
@milend Oh, totally. I just think people forget that we weren't on an annual cycle back then. - View other replies
-
@jamesthomson@milend I think mostly power users and developers care that much about the quality of software at Apple. - View other replies
-
@lucvandal@jamesthomson I think there's a lot of anger, alienation and disappointment within devs stemming from App Store policies. -
@lucvandal@jamesthomson and the ecosystem itself is being destroyed / transformed into something that has questionable long term value. -
@milend@jamesthomson Its just the accumulation of many annoyances+frustrations amongst developers but still sad to see Apple in that state. -
@lucvandal@jamesthomson Precisely, it just keeps on piling and piling and piling and at some point, people just snap.
-
-
-
@jamesthomson I still think it's the boldest move any tech company has done in terms of software, especially as it cost $29 -
@pilky It made a ton of sense, too. -
@jamesthomson Well yeah, and things weren't quite as bad back then in terms of speed and stability -
@pilky Agreed. Though I seem to remember it happened because Leopard wasn't exactly great :)
-
-
-
@jamesthomson Keep in mind though, Snow Leopard did have new features. -
@jeffkibuule Not really a huge amount though, that was the point. -
@jamesthomson Snow Leopard had tons of developer features though, but less advertisable, not so marketing driven. Still very important.
-
-
-
@jamesthomson like Debian. Now we are getting OS X releases on the pace and rate of change of Fedora. -
@brian_reiter And I don't think that's a good thing… -
@jamesthomson when you think about it in these terms, it’s amazing OS X works so well and upgrades are smooth. Fedora not so much.
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
James Thomson
Milen Dzhumerov
Luc Vandal
Martin Pilkington
Joefrey Kibuule, MD
Brian A. Reiter